Physician profile

Sofia Lakhdar

Cardiovascular Disease · Phoenix, AZ

NPI 1225599574

$3,242.85

in general payments reported to CMS, 2019-2025

17 companies · $1,260 in 2025

The $1,260 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,040.49
Education$138.48

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $483.13 2023-2025
Abbott Laboratories $425.67 2024-2025 Gallant, Ensite, Assurity
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $400.49 2024-2025 Lifevest
Novo Nordisk INC $325.54 2024-2025 Wegovy, Ozempic
Abiomed $268.93 2023-2025 Impella
Kestra Medical Technology Services, INC. $227.90 2024-2025 Assure Wcd
Astrazeneca Pharmaceuticals LP $199.76 2022-2025 Farxiga
Biosense Webster, INC. $170.09 2023-2024 Carto 3, Qdot Micro Catheter
Amgen INC. $168.48 2022-2024 Repatha
Bridgebio Pharma, INC. $146.38 2025 Attruby
Janssen Pharmaceuticals, INC $117.36 2023-2024 Xarelto
Pfizer INC. $107.64 2022-2025
E.R. Squibb & Sons, L.L.C. $85.50 2023-2025 Camzyos
Alnylam Pharmaceuticals INC. $41.80 2023-2024 Onpattro
Boehringer Ingelheim Pharmaceuticals, INC. $26.73 2023 Jardiance
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Inari Medical, INC. $23.93 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Lantheus Medical Imaging, INC. $23.52 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sofia Lakhdar

$3,242.85

in general payments reported 2019-2025

Years
2022-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $1,260 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/11345473/sofia-lakhdar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.